Format

Send to

Choose Destination
Lancet Oncol. 2018 Jan;19(1):23-24. doi: 10.1016/S1470-2045(17)30916-6.

Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes.

Author information

1
Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
2
Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
3
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
4
Department of Medicine, Medical Oncology, Yale School of Medicine, New Haven, CT, USA. Electronic address: sarah.goldberg@yale.edu.
PMID:
29304353
DOI:
10.1016/S1470-2045(17)30916-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center